SOURCE: Equity Markets, Inc.

June 17, 2011 09:00 ET

Research Report on StemCells, Inc. and Life Technologies Corporation - Biotech Gains Healthy Options

MACAU--(Marketwire - Jun 17, 2011) - Today, www.EquityMarketsInc.com announced its research report highlighting StemCells, Inc. (NASDAQ: STEM) and Life Technologies Corporation (NASDAQ: LIFE). Full content and research is available at www.EquityMarketsInc.com/research.php.

Several new innovations within the healthcare field have maintained an influx of new interest to the industry. Combining medical technology with human touch, the healthcare industry diagnoses, treats, and administers care around the clock- responding to the needs of millions of people. Firms with well-defined growth prospects and generous dividend yields should sustain as they should perform relatively well over the coming quarters. Pharmaceuticals should remain one of the widest-margin industries, with prospects enhanced by demographic growth in the elderly and new drugs stemming from discoveries in genomics and biotechnology.

Equity Markets has reviewed StemCells, Inc. because it is engaged in the research, development, and commercialization of stem cell therapeutics and related enabling technologies for academia and industry. The Company is focused on cellular medicine, or the use of stem and progenitor cells as the basis for therapeutics and therapies, and enabling technologies for stem cell research, or the use of cells and related technologies to enable stem cell-based research and drug discovery and development. The primary research and development efforts are focused on cellular medicine, where StemCells seeks to identify and develop stem and progenitor cells as therapeutic agents. The full research report on StemCells, Inc. (NASDAQ: STEM) is available here: www.EquityMarketsInc.com/researchfile4634.php.

Equity Markets is covering Life Technologies Corporation as a global life sciences company. Life Technologies delivers a range of products and services, including systems, instruments, reagents, software, and custom services. Its portfolio of products include technologies for Polymerase Chain Reaction (PCR), sample preparation, cell culture, ribonucleic acid (RNA) interference analysis, functional genomics research, proteomics and cell biology applications, capillary electrophoresis based sequencing, next generation sequencing, as well as clinical diagnostic applications, forensics, animal, food, pharmaceutical and water testing analysis.. The full research report on Life Technologies Corporation (NASDAQ: LIFE) is available here: www.EquityMarketsInc.com/researchfile4891.php.

About Equity Markets
Our mission at Equity Markets is to be the best source of content and research, while educating, enlightening and informing investors. Equity Markets combines street smart analysts and professional market researchers to provide investors with detailed company profiles and market coverage.

Contact Information